Hunter Smith

Hunter Smith

Director of Finance/CFO at RHYTHM PHARMACEUTICALS, INC.

Net worth: 13 M $ as of 2026-06-29

58 year
Health Technology
Consumer Services
Finance

Profile

Hunter C.
Smith
is currently Director at Vanqua Bio, Inc. and Chief Financial Officer & Treasurer at Rhythm Pharmaceuticals, Inc. since 2021.
Former roles include Independent Director at Genesee & Wyoming, Inc. from 2015 to 2019, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Director-Commodities Finance at UBS AG (Stamford Branch) from 1992 to 1999, CFO-Inflammation & Immunology and VP-Finance at Celgene Corp.
from 2013 to 2017, Chief Financial Officer-Sugar & Bioenergy Segment at Bunge Ltd. from 2010 to 2013, and Credit Analyst at Manufacturers Hanover Corp.
from 1990 to 1992.
Education includes undergraduate studies at Northwestern University and an MBA from The Leonard N Stern School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-17 119,611 ( 0.17% ) 13 M $ 2026-06-29

Hunter Smith active positions

CompaniesPositionStart
RHYTHM PHARMACEUTICALS, INC. Director of Finance/CFO 2017-06-30
Director/Board Member -

Former positions of Hunter Smith

CompaniesPositionEnd
SPYRE THERAPEUTICS, INC. Director/Board Member 2023-11-21
GENESEE & WYOMING INC. Director/Board Member 2019-12-29
CELGENE Corporate Officer/Principal 2017-06-30
Public Communications Contact 2002-12-31
Corporate Officer/Principal 1998-12-31
See the detail of Hunter Smith's experience

Training of Hunter Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Transportation

Process Industries

Health Technology

Health Technology

Consumer Services

Finance

Finance

Consumer Services

Commercial Services